Asian Spectator

Men's Weekly

.

Actinogen announces further positive results on depression in the XanCIDD phase 2a trial

  • Written by PR Newswire Asia - Asian Spectator
Actinogen announces further positive results on depression in the XanCIDD phase 2a trial

Durable benefits previously reported for the MADRS depression scale are supported by the patient-reported outcome of PGI-S and new MADRS responder analyses that underscore benefit at week 10 with a 50% higher rate of remission of depression  

SYDNEY, Aug. 26, 2024 /PRNewswire/ -- Actinogen Medical ASX: ACW ("ACW" or "the Company") announces...

Magazine

Diplomasi FOMO Prabowo: Simbolis, reaktif, berisiko mengancam legitimasi

Presiden Prabowo Subianto menghadiri BRICS Leaders Virtual Meeting dari kediaman pribadinya di Kertanegara, Jakarta Selatan, pada Senin, 8 September 2025.Cahyo/Biro Pers Sekretariat Presiden, CC BY ...

Anak ikut demo: Peran negara dalam memfasilitasi dan melindungi aksi protes

(David Wadie Fisher-Freberg/Wikimedia Commons), CC BY● Banyak anak dalam demonstrasi menjadi korban kekerasan dan penyimpangan hukum.● Demonstrasi bukanlah ruang aman, tapi larangan justru...

Bagaimana revisi KUHAP bisa memperparah pelemahan KPK

(Arraihansyah/Shutterstock)● Revisi KUHAP menjadikan penyidik KPK di bawah kendali polisi, tak lagi independen.● Upaya paksa seperti penyelidikan hingga penyadapan dalam revisi KUHAP membu...